Our results indicate that glycolysis of IDECs may be activated through FcεRI and TLR2 to upregulate inflammatory factors, suggesting that danger signals from bacteria or allergens might evoke an inflammatory response from AD through the glycolysis pathway. The gene discussed is FCER1A; the disease is Alzheimer disease.